The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...

Washington researchers and care providers are struggling to keep up with new chemicals in the region’s illicit drug supply.

Clinical trials are underway in Colorado for a new drug that could extend a dog's lifespan. Loyal, a San Francisco based ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...